Dainippon Sumitomo Pharma America Selects SAS® Solutions OnDemand
News Nov 03, 2009
SAS has announced that Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. pharmaceutical company, has selected SAS Solutions OnDemand: Drug Development as a technology platform for clinical development. With SAS OnDemand, DSPA will have a globally accessible, fully regulatory compliant repository for all of its clinical data.
The SAS OnDemand service has allowed DSPA to move with limited internal resources, in creating its centralized SAS development environment. By letting SAS handle all system provisioning and deployment activities, DSPA resources are free to focus on other mission critical business activities.
SAS Solutions OnDemand: Drug Development is a cost-effective alternative to an enterprise SAS Drug Development implementation, with all embedded enterprise-level content management and analytical capabilities. SAS, through its OnDemand solution, directly supports all hardware and software installation, system administration, validation and maintenance, freeing DSPA from these burdensome responsibilities.
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Algorithm Predicts Life Expectancy After Heart AttackNews
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more personalized assessments of people who are awaiting heart transplants, which in turn could enable health care providers to make better use of limited life-saving resources and potentially reduce health care costs.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018